Survival from Localized Breast Cancer: Variability Across Trials and Registries-Reference-Cited by-同舟云学术

Survival from Localized Breast Cancer: Variability Across Trials and Registries

Published:1993 Issue:4 Volume:9 Page:539-553
ISSN:0266-4623
Container-title:International Journal of Technology Assessment in Health Care
language:en
Short-container-title:Int J Technol Assess Health Care

Author:

Klawansky Sidney,Berkey Catherine,Shah Nirav,Mosteller Frederick,Chalmers Thomas C.

Abstract

AbstractAge-specific (<50, 50–69 years) 10-year survival proportions in four European trials for node-negative, Stage I and II breast cancer patients differ significantly. These patients, identified as having the same stage as localized-breast cancer patients in the End Results Registry of the U.S. National Cancer Institute, had pooled survival proportions for the two age groups (0.713, 0.579) close to those of the registry (0.713, 0.607).

Publisher

Cambridge University Press (CUP)

Subject

Health Policy

Reference22 articles.

1. Cancer incidence and mortality in metropolitan Detroit, 1973–1977. Surveillance, epidemiology, and end results: Incidence and mortality data;Swanson;National Cancer Institute Monograph,1981

2. Thirty Years Experience with Breast Cancer Clinical Trials at the Christie Hospital in Manchester - Clinical Aspects -

3. Clinical trials in malignant disease

4. MANCHESTER REGIONAL BREAST STUDY

5. Some Statistical Methods for Combining Experimental Results

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frederick Mosteller (1916–2006): Mentoring, A Memoir;International Journal of Technology Assessment in Health Care;2007-01

2. Competing or Complementary?: Ethical Considerations and the Quality of Randomized Trials;International Journal of Technology Assessment in Health Care;1996